Abbott (ABT) CEO says nutrition business performance to remain challenged in H1 '26 and expects return to growth in H2 - conference call
Importance
Level 1
#ABBOTT LABORATORIES#ABT.US#EQUITIES#EU SESSION#US SESSION#HEALTH CARE EQUIPMENT#HEALTH CARE EQUIPMENT & SUPPLIES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#ABT#US EQUITIES